Operating Income (Loss) in USD of MYRIAD GENETICS INC from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
MYRIAD GENETICS INC quarterly/annual Operating Income (Loss) history and change rate from Q1 2010 to Q3 2025.
  • MYRIAD GENETICS INC Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$23,300,000.000, a 16.5% decline year-over-year.
  • MYRIAD GENETICS INC Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$420,600,000.000, a 263% decline year-over-year.
  • MYRIAD GENETICS INC annual Operating Income (Loss) for 2024 was -$123,500,000.000, a 52% increase from 2023.
  • MYRIAD GENETICS INC annual Operating Income (Loss) for 2023 was -$257,400,000.000, a 83.1% decline from 2022.
  • MYRIAD GENETICS INC annual Operating Income (Loss) for 2022 was -$140,600,000.000, a 26.2% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

MYRIAD GENETICS INC Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$420,600,000 -$23,300,000 -$3,300,000 -16.5% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 -$417,300,000 -$329,200,000 -$292,700,000 -8% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 -$124,600,000 -$29,000,000 -$1,100,000 -3.9% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025
Q4 2024 -$123,500,000 -$39,100,000 -$7,700,000 -24.5% 01 Oct 2024 31 Dec 2024 10-K 28 Feb 2025
Q3 2024 -$115,800,000 -$20,000,000 +$40,100,000 +66.7% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025
Q2 2024 -$155,900,000 -$36,500,000 +$77,200,000 +67.9% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025
Q1 2024 -$233,100,000 -$27,900,000 +$24,300,000 +46.6% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025
Q4 2023 -$257,400,000 -$31,400,000 +$20,800,000 +39.8% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 -$278,200,000 -$60,100,000 -$15,100,000 -33.6% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024
Q2 2023 -$263,100,000 -$113,700,000 -$95,900,000 -5.4% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 -$167,200,000 -$52,200,000 -$26,600,000 -1% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024
Q4 2022 -$140,600,000 -$52,200,000 -$9,100,000 -21.1% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2025
Q3 2022 -$131,500,000 -$45,000,000 +$34,900,000 +43.7% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 -$166,400,000 -$17,800,000 +$3,000,000 +14.4% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023
Q1 2022 -$169,400,000 -$25,600,000 +$21,100,000 +45.2% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 -$190,500,000 -$43,100,000 +$5,100,000 +10.6% 01 Oct 2021 31 Dec 2021 10-K 28 Feb 2024
Q3 2021 -$195,600,000 -$79,900,000 -$40,300,000 -1% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022
Q2 2021 -$155,300,000 -$20,800,000 +$47,500,000 +69.5% 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022
Q1 2021 -$202,800,000 -$46,700,000 +$87,000,000 +65.1% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022
Q4 2020 -$289,800,000 -$48,200,000 -$39,400,000 -4.5% 01 Oct 2020 31 Dec 2020 10-KT 16 Mar 2021
Q3 2020 -$250,400,000 -$39,600,000 -$18,700,000 -89.5% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 -$231,700,000 -$68,300,000 -$62,700,000 -11.2% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021
Q1 2020 -$169,000,000 -$133,700,000 -$139,600,000 -23.7% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021
Q4 2019 -$29,400,000 -$8,800,000 -$14,900,000 -2.4% 01 Oct 2019 31 Dec 2019 10-KT 16 Mar 2021
Q3 2019 -$14,500,000 -$20,900,000 -$22,100,000 -18.4% 01 Jul 2019 30 Sep 2019 10-KT 16 Mar 2021
Q2 2019 $7,600,000 -$5,600,000 -$23,400,000 -1.3% 01 Apr 2019 30 Jun 2019 10-KT 16 Mar 2021
Q1 2019 $31,000,000 $5,900,000 -$7,900,000 -57.2% 01 Jan 2019 31 Mar 2019 10-KT 16 Mar 2021
Q4 2018 $38,900,000 $6,100,000 -$200,000 -3.2% 01 Oct 2018 31 Dec 2018 10-KT 16 Mar 2021
Q3 2018 $39,100,000 $1,200,000 -$82,800,000 -98.6% 01 Jul 2018 30 Sep 2018 10-KT 16 Mar 2021
Q2 2018 $121,900,000 $17,800,000 -$1,100,000 -5.8% 01 Apr 2018 30 Jun 2018 10-K 13 Aug 2019
Q1 2018 $123,000,000 $13,800,000 +$8,300,000 +1.5% 01 Jan 2018 31 Mar 2018 10-K 13 Aug 2019
Q4 2017 $114,700,000 $6,300,000 -$10,900,000 -63.4% 01 Oct 2017 31 Dec 2017 10-K 13 Aug 2019
Q3 2017 $125,600,000 $84,000,000 +$76,900,000 +10.8% 01 Jul 2017 30 Sep 2017 10-K 13 Aug 2019
Q2 2017 $48,700,000 $18,900,000 -$3,400,000 -15.2% 01 Apr 2017 30 Jun 2017 10-K 24 Aug 2018
Q1 2017 $52,100,000 $5,500,000 -$37,100,000 -87.1% 01 Jan 2017 31 Mar 2017 10-K 24 Aug 2018
Q4 2016 $89,200,000 $17,200,000 -$28,000,000 -61.9% 01 Oct 2016 31 Dec 2016 10-K 24 Aug 2018
Q3 2016 $117,200,000 $7,100,000 -$36,200,000 -83.6% 01 Jul 2016 30 Sep 2016 10-K 24 Aug 2018
Q2 2016 $153,400,000 $22,300,000 -$13,400,000 -37.5% 01 Apr 2016 30 Jun 2016 10-K 24 Aug 2018
Q1 2016 $166,800,000 $42,600,000 +$6,900,000 +19.3% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017
Q4 2015 $159,900,000 $45,200,000 +$8,900,000 +24.5% 01 Oct 2015 31 Dec 2015 10-Q 08 Feb 2017
Q3 2015 $151,000,000 $43,300,000 +$17,400,000 +67.2% 01 Jul 2015 30 Sep 2015 10-Q 02 Nov 2016
Q2 2015 $133,600,000 $35,700,000 -$17,510,000 -32.9% 01 Apr 2015 30 Jun 2015 10-K 24 Aug 2018
Q1 2015 $151,110,000 $35,700,000 -$19,587,000 -35.4% 01 Jan 2015 31 Mar 2015 10-Q 04 May 2016
Q4 2014 $170,697,000 $36,300,000 -$46,699,000 -56.3% 01 Oct 2014 31 Dec 2014 10-Q 03 Feb 2016
Q3 2014 $217,396,000 $25,900,000 -$57,004,000 -68.8% 01 Jul 2014 30 Sep 2014 10-Q 04 Nov 2015
Q2 2014 $274,400,000 $53,210,000 -$12,704,000 -19.3% 01 Apr 2014 30 Jun 2014 10-K 10 Aug 2016
Q1 2014 $287,104,000 $55,287,000 -$2,631,000 -4.5% 01 Jan 2014 31 Mar 2014 10-Q 06 May 2015
Q4 2013 $289,735,000 $82,999,000 +$27,413,000 +49.3% 01 Oct 2013 31 Dec 2013 10-Q 04 Feb 2015
Q3 2013 $262,322,000 $82,904,000 +$34,322,000 +70.6% 01 Jul 2013 30 Sep 2013 10-Q 05 Nov 2014
Q2 2013 $228,000,000 $65,914,000 +$18,629,000 +39.4% 01 Apr 2013 30 Jun 2013 10-K 12 Aug 2015
Q1 2013 $209,371,000 $57,918,000 +$11,822,000 +25.6% 01 Jan 2013 31 Mar 2013 10-Q 07 May 2014
Q4 2012 $197,549,000 $55,586,000 +$10,121,000 +22.3% 01 Oct 2012 31 Dec 2012 10-Q 05 Feb 2014
Q3 2012 $187,428,000 $48,582,000 +$7,110,000 +17.1% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013
Q2 2012 $180,318,000 $47,285,000 +$5,508,000 +13.2% 01 Apr 2012 30 Jun 2012 10-K 13 Aug 2014
Q1 2012 $174,810,000 $46,096,000 +$4,272,000 +10.2% 01 Jan 2012 31 Mar 2012 10-Q 08 May 2013
Q4 2011 $170,538,000 $45,465,000 +$6,879,000 +17.8% 01 Oct 2011 31 Dec 2011 10-Q 06 Feb 2013
Q3 2011 $163,659,000 $41,472,000 +$5,881,000 +16.5% 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012
Q2 2011 $157,778,000 $41,777,000 01 Apr 2011 30 Jun 2011 10-K 14 Aug 2013
Q1 2011 $41,824,000 +$8,599,000 +25.9% 01 Jan 2011 31 Mar 2011 10-Q 02 May 2012
Q4 2010 $38,586,000 01 Oct 2010 31 Dec 2010 10-Q 01 Feb 2012
Q3 2010 $35,591,000 01 Jul 2010 30 Sep 2010 10-Q 02 Nov 2011
Q1 2010 $33,225,000 01 Jan 2010 31 Mar 2010 10-Q 04 May 2011

MYRIAD GENETICS INC Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$123,500,000 +$133,900,000 +52% 01 Jan 2024 31 Dec 2024 10-K 28 Feb 2025
2023 -$257,400,000 -$116,800,000 -83.1% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025
2022 -$140,600,000 +$49,900,000 +26.2% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025
2021 -$190,500,000 +$99,200,000 +34.2% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024
2020 -$289,700,000 -$297,300,000 -39.1% 01 Jan 2020 31 Dec 2020 10-K 25 Feb 2022
2019 $7,600,000 -$114,300,000 -93.8% 01 Jul 2018 30 Jun 2019 10-K 25 Feb 2022
2018 $121,900,000 +$77,900,000 +1.8% 01 Jul 2017 30 Jun 2018 10-KT 16 Mar 2021
2017 $44,000,000 -$109,400,000 -71.3% 01 Jul 2016 30 Jun 2017 10-K 13 Aug 2019
2016 $153,400,000 +$19,800,000 +14.8% 01 Jul 2015 30 Jun 2016 10-K 24 Aug 2018
2015 $133,600,000 -$140,800,000 -51.3% 01 Jul 2014 30 Jun 2015 10-K 24 Aug 2018
2014 $274,400,000 +$46,400,000 +20.4% 01 Jul 2013 30 Jun 2014 10-K 10 Aug 2016
2013 $228,000,000 +$47,682,000 +26.4% 01 Jul 2012 30 Jun 2013 10-K 12 Aug 2015
2012 $180,318,000 +$22,540,000 +14.3% 01 Jul 2011 30 Jun 2012 10-K 13 Aug 2014
2011 $157,778,000 +$22,703,000 +16.8% 01 Jul 2010 30 Jun 2011 10-K 14 Aug 2013
2010 $135,075,000 01 Jul 2009 30 Jun 2010 10-K 15 Aug 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.